The FDAs Race and Ethnic Diversity Plan Guidance: How prepared is your organization?
To align diversity plans to FDA's draft diversity guidance will require sponsors to shift from trial-level considerations to disease-level planning and partnership strategies. In this virtual roundtable Xoli Belgrave, Senior Director, Patient Innovation Center, is joined by other CRO, site and pharma SMEs to discuss the need for early engagement with sponsors and research partners as well as site-level strategies to reach underrepresented patient populations.
Related Insights
Article
Australia: Infrastructure and Innovations for Clinical Trials
Aug 28, 2023
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Video
The 2024 FDA Diversity Guidance Update: What does it mean for patients, sites, sponsors and CROs
Aug 22, 2024
Blog
Including patients in DCT design
Sep 13, 2022
Article
Decentralized clinical trials - A more patient-centric approach
May 10, 2021
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Report
New Medicines, Novel Insights: Achieving patient-guided drug development
Oct 30, 2023
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
A patient-centric approach to managing clinical trial complexity
Jul 13, 2021
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Related Insights
Article
Australia: Infrastructure and Innovations for Clinical Trials
Aug 28, 2023
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Video
The 2024 FDA Diversity Guidance Update: What does it mean for patients, sites, sponsors and CROs
Aug 22, 2024
Blog
Including patients in DCT design
Sep 13, 2022
Article
Decentralized clinical trials - A more patient-centric approach
May 10, 2021
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Report
New Medicines, Novel Insights: Achieving patient-guided drug development
Oct 30, 2023
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
A patient-centric approach to managing clinical trial complexity
Jul 13, 2021
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021